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ABSTRACT
Serotonin (5-HT), a neurotransmitter synthesized
from tryptophan, has been proposed as a feedback in-
hibitor of lactation.We determined that the gene coding
for tryptophan hydroxylase 1, the rate-limiting enzyme
for 5-HT synthesis, is expressed in bovine mammary
epithelial cells in vitro and is upregulated by prolactin.
In addition, 5-HT reduced the expression of α-lactalbu-
min and casein genes in vitro. Furthermore, inhibiting
5-HT synthesis with p-chlorophenylalanine or blocking
the 5-HT receptor with methysergide (METH) in-
creased milk protein gene expression. We then evalu-
ated effects of intramammary 5-HT or METH infusion
on production and milk composition in 6 multiparous
Holstein cows. Cows were assigned to a repeated mea-
sures design of contralateral intramammary infusions
ofMETH (20mg/quarter per d) or saline for 3 d followed
by a 7-d washout period before administering 5-HT (50
mg/quarter/d) or SAL for 3 d. For each udder half, milk
yield was recorded twice and composition was deter-
mined once per day. Blood samples were harvested each
day for plasma to determine glucose and nonesterified
fatty acid concentrations. Evaporative heat loss, respi-
ration rate, left and right udder temperatures, and rec-
tal temperatures were obtained after each milking to
evaluate possible systemic effects of infusions. During
METH and saline infusions milk yield increased 10.9%.
During 5-HT and saline infusion milk yield decreased
11.1%. Milk yield and physiological responses sug-
gested intramammary 5-HT and METH doses were
high enough to cause systemic effects. Infusing saline,
METH, and 5-HT increased milk SCC. Infusing 5-HT
tended to reduce mean lactose concentration (4.3 vs.
4.6%) relative to saline. Milk protein content was de-
creased by METH and SAL (2.0%) and was increased
(5.8%) by 5-HT followed by a 33%decrease postinfusion.
Infusion of METH increased evaporative heat loss 11%,
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which decreased 11% postinfusion. Infusions of 5-HT
or METH did not affect plasma nonesterified fatty acid
or glucose concentrations, respiration rate, or milk fat
content. We conclude 5-HT infusion reduced milk syn-
thesis, whereas blocking the 5-HT receptor with METH
increased milk synthesis. Doses of 5-HT and METH
used in this study likely resulted in systemic effects.
These data support the concept that 5-HT is a feedback
inhibitor of lactation in the bovine.
Key words: serotonin, milk production, dry-off, feed-
back inhibition of lactation
INTRODUCTION
Serotonin (5-HT) is a hormone and neurotransmitter
synthesized from L-tryptophan and has been proposed
to be a component of the autocrine-paracrine homeo-
static feedback mechanism (feedback inhibitor of lacta-
tion), which opposes endocrine stimulation ofmammary
development and milk secretion (Wilde et al., 1995;
Matsuda et al., 2004). The rate-limiting enzyme in-
volved in synthesis of 5-HT is tryptophan hydroxylase
(TPH). The TPH enzyme converts L-tryptophan to 5-
hydroxy-L-tryptophan. A second enzyme involved in 5-
HT synthesis is aromatic amino acid decarboxylase,
which is responsible for the conversion of 5-hydroxy-L-
tryptophan to 5-HT. Recently, 5-HT biosynthesis was
induced in rodent mammosphere cultures by prolactin
(PRL), and β-casein mRNA expression was suppressed
by supplemental 5-HT (Matsuda et al., 2004). The same
investigators demonstrated that systemic 5-HT admin-
istered to lactating rodents reduced litter weight gain,
whereas administering a 5-HT receptor blocker in-
creased litter weight gain, suggesting an up and down
regulation of milk synthesis, respectively. Previous
studies have reported presence of 5-HT in cow’s milk
(Zia et al., 1985) and that 5-HT is a potent vasoconstric-
tor in the sow mammary gland (Busk et al., 1999).
Serotonin is also known to cause constriction of the
smooth muscle in teat wall and sphincter (Vandeputte-
Van Messon et al., 1985). However, to date, no one
has demonstrated that 5-HT has any effects on gene
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expression in bovinemammary epithelial cells (BMEC)
or has studied its effects on milk yield (MY) in lactating
dairy cows. Our study objectives were to 1) evaluate
the effects of PRL on TPH-1 gene expression in BMEC
in a lactogenic model, 2) evaluate the effects of 5-HT
and blockade of 5-HT synthesis, binding, or both on
milk protein gene expression in BMEC in a lactogenic
culture model, and 3) evaluate the effects of intramam-
mary infusions of methysergide (METH; a nonselective
5-HT receptor blocker) and 5-HT on milk synthesis and
composition. Additionally, the potential systemic ef-
fects of METH and 5-HT infusions were evaluated by
measuring evaporative heat loss (EVHL), respiration
rate (RR), left udder temperature (LU), right udder
temperature (RU), rectal temperature (RT), and circu-
lating concentrations of energetic metabolites (glucose
and NEFA). We hypothesized that 1) TPH-1 is ex-
pressed in bovine mammary cells and is upregulated
by PRL, 2) 5-HT would decrease milk protein gene ex-
pression and blocking either its synthesis or binding to
its receptor(s) would increase milk protein gene expres-
sion and, finally, 3) intramammary infusion of 5-HT
would decrease MY, whereas blocking the 5-HT recep-
tor(s) with METH would increase MY in lactating
dairy cows.
MATERIALS AND METHODS
Cell Culture and Sampling
Tissue dissociation, BMEC isolation, and preparation
of Type 1 collagen were performed according to Collier
et al. (2006). Cell isolates were thawed, resuspended
in DMEM/F-12, mixed with neutralized collagen, and
cultured in 24-well plates as described (Collier et al.,
2006). Stock collagen was neutralized on ice using 0.75
N NaOH. A base layer (300 L/well) of neutralized
collagen was added to a 24-well tissue culture plate
(Falcon, BD Biosciences, San Jose, CA) and allowed to
gel at room temperature for 5 min. The resuspended
cells were then added to the remaining neutralized col-
lagen, and a 500-L collagen-cell suspension was
seeded directly onto the base layer of each well. Colla-
gen was then allowed to gel for 20 to 30 min at 37°C;
then appropriate medium was added to each well; and
plates were then placed in an incubator at 37°C, 5%
CO2 in air.
Cultures initially received a serum-free basal me-
dium consisting of DMEM/F-12, 0.1% BSA, antibiotic-
antimycotic (100U/mL of penicillin, 100g/mL of strep-
tomycin, and 0.25 g of amphotericin B; 15240, In-
vitrogen Corp., Carlsbad, CA). The growth factors (re-
combinant human IGF-I, 100 ng/mL; A. F. Parlow,
NIDDK, Torrance, CA) and recombinant-human epi-
dermal growth factor (EGF; 25 ng/mL; 13247-051, In-
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vitrogen Corp.) were included to induce proliferation
and ductal development. Media was exchanged every
48 h for 8 d. Lactogenesis was induced after 8 d using
the same basal medium without EGF, plus hydrocorti-
sone (10 ng/mL; H-0396, Sigma, St. Louis, MO), recom-
binant bovine PRL (100 ng/mL; A. F. Parlow, NIDDK,
Torrance, CA) and gel release (detachment of the poly-
merized collagen from the surface of the well). The ef-
fects of lactogenesis on TPH-1 gene expression were
determined with and without PRL in the lactogenic
medium. Samples receiving the lactogenic complexwith
PRL served as a positive control and without PRL
served as a negative control to which treatments were
compared: 4.2 g/mL (20 M 5-HT; Sigma) with and
without PRL, 9.38 g/mL (20 M METH; Sigma) with
and without PRL, and 3.98 g/mL [20 M p-chlorophe-
nyalanine (PCPA); Sigma] a 5-HT synthesis inhibitor
with and without PRL. A total of 4 gels per replicate
were used for RNA extraction, and 4 separate replicates
of this design were carried out.
Sample Preparation
Total RNA was isolated from cell culture samples
using TRIzol Reagent (Invitrogen). For precipitation,
half of the recommended volume of isopropanol was
used, with the other half being replaced with a salt
solution (0.8 M sodium citrate, 1.2 M NaCl). The RNA
concentration, purity and integrity was confirmed on
the 2100 BioAnalyzer (Agilent Technologies, Palo Alto,
CA), as well as spectrophotometrically using a Nano-
drop (ND-1000; Nanodrop Technologies, Wilmington,
DE).
Real-Time Quantitative PCR
One microgram of total RNA was DNase-treated at
room temperature for 15 min in 10-L reaction con-
taining 0.5 U of DNase I (amplification grade, In-
vitrogen). The EDTAwas added to a final concentration
of 2.5 mM, and the DNase was inactivated at 65°C for
15 min. Resulting RNA was used for cDNA synthesis
(20-L reactions) using iScript cDNA synthesis Kit
(BioRad, Hercules, CA). Analysis was conducted using
the iCycler IQ Real-Time PCR Detection System (Bio-
Rad). Hypoxanthine phosphoribosyltransferase I
(HPRT1) was used as the internal control gene follow-
ing standard curve analysis across all treatment group
samples [ribosomal protein (S18) andGAPDHwere also
evaluated]. Resulting gene expression data were calcu-
lated and analyzed based on the 2−∆∆CT method (Livak
and Schmittgen, 2001). Primer sequences are shown in
Table 1.
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Table 1. Sequences of primers used for quantitative real-time reverse transcription-PCR
Primer1 Forward primer (5′ to 3′) Reverse primer (5′ to 3′)
β-Casein GCTATGGCTCCTAAGCACAAAGA GGAAACATGACAGTTGGAGGAAG
α-Lactalbumin CTCTGCTCCTGGTAGGCATC ACAGACCCATTCAGGCAAAC
TPH1 AGAGAATTTACCAAGACAATCAAGC CTTAGCAAGGGCATCACTGAC
HPRT GAGAAGTCCGAGTTGAGTTTGGAA GGCTCGTAGTGCAAATGAAGAGT
1β-Casein was run at an annealing temperature of 64°C, α-lactalbumin at 62°C, and tryptophan hydroxy-
lase-1 (TPH-1) at 61°C. Hypoxanthine phosphoribosyltransferase (HPRT) was used as the housekeeping
gene and was run at all annealing temperatures used for the primers of interest.
Animals and Experimental Design
The University of Arizona Institutional Animal Care
and Use Committee approved all procedures involv-
ing animals.
Cows were housed at the University of Arizona Ag-
ricultural Research Complex in individual tie stalls and
fed a TMR formulated to meet or exceed NRC recom-
mendations (NRC, 2001). Cows were exposed to a 12-
h light/dark cycle and thermoneutral temperature of
20°C. Diets were fed ad libitum at 0500 and 1700 h,
and animals had ad libitum access to water. The diet
was primarily composed of alfalfa hay and corn (Table
2). Ration DM percentage and nutrient composition
(Dairy One, Ithaca, NY) of the TMR were determined
from a composite sample containing samples of feed
from each week of the experiment. Cows were milked
twice daily at 0500 and 1700 h during the 28-d trials.
Feed refusals were weighed and recorded before the
0500 h feeding. For statistical analyses, MY was re-
corded twice daily for each half-udder, and values were
collapsed into a mean representative of the 6 milkings
pretreatment infusion (period 1), 6 milkings of treat-
ment infusion (period 2), and the 6 milkings posttreat-
ment infusion (period 3). As a consequence, there were
3 periods associatedwith theMETHand5-HT infusions
(3 periods/infusate). Milk yield was also calculated for
thewhole udder.Milk sampleswere obtained daily from
each half-udder and analyzed for fat, true protein, lac-
tose, and SCC (Arizona DHIA, Tempe, AZ). Milk fat,
protein, and lactose were analyzed using AOAC-ap-
proved infrared analysis (AOAC, 2000); SCC was ana-
lyzed using AOAC-approved cell-staining techniques
(AOAC, 2000). The International Dairy Federation and
the Food and Drug Administration certified all equip-
ment used in the analyses.
The study design used 6 multiparous, Holstein cull
cows in late lactation (436 ± 59 DIM; 703 ± 68 kg of
BW). Cows were removed from bST 1 mo prior to the
start of the experiment. Cows selected for the study
were healthy and had SCC <500,000 cells/mL. Within
each animal, prior to METH treatment, contralateral
udder halves were randomly assigned to an infusion
of METH or SAL. During the 5-HT treatment period,
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contralateral udder halves that previously received
SAL during the METH treatment received 5-HT, and
contralateral udder halves that previously received
METHreceivedSAL. Immediately after each treatment
infusion, all quarters received a short-acting antibiotic
to prevent mastitis (Amoxi-Mast, amoxicillin trihy-
drate, Pfizer, Kalamazoo, MI). All milk from the study
was discarded, and the animalswere humanely euthan-
ized and composted following the study.
Intramammary Infusion
Animals were allowed to acclimate for 7 d in the
environmentally controlled roomsunder thermoneutral
conditions and remained under thermoneutral condi-
tions for the remainder of the study. Both METH and
5-HT were solubilized in sterile saline (at 2 and 17 mg/
mL, respectively). Solutions were sterilized by syringe
filtration (0.22 m) during dosing. Before administra-
tion, milk samples from all quarters of all cows were
evaluated for mastitis using the California Mastitis
Test. On d 8, 20 mg/quarter per d of METH (# M-137;
Sigma) were infused (10 mg/quarter per milking) for
3 d in contralateral half-udders. Control udder-halves
received a sterile SAL solution. After 3 d of METH
infusions, animals were allowed a 7-d washout period.
Following the washout period, udder halves previously
receiving METH were assigned as the control udder
Table 2. Composition of the TMR (dry-weight basis) fed to late lacta-
tion cows1,2
Ingredient % TMR
Alfalfa hay 33.34
Corn (steam-flaked) 7.66
Barley 7.66
Molasses (cane) 0.75
PF-45 high-producer premix 4.59
1Diet was 54% DM and contained 20.5% CP, 0.75 Mcal NEl/kg of
DM, 26.2% ADF, and 31.4% NDF based upon analysis of the TMR.
Analysis was conducted by Dairy One Inc., Ithaca, NY.
2Contained 1.14 × 103 IU/kg of vitamin A, 1.09 × 102 IU/kg of
vitamin D, 3.64 IU/kg of vitamin E, 0.55% Cl, 1.84% K, 0.27% Mg,
0.36% Na, 0.40% P, 0.28% S, 1.39 ppm Co, 19.92 ppm Cu, 244.6 ppm
Fe, 0.82 ppm I, 65.4 ppm Mn, 0.67 ppm Mo, 0.33 ppm Se, 62.4 ppm
Zn.
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halves (SAL), and contralateral udder halves pre-
viously receiving SAL received 50 mg/quarter per d of
5-HT (Sigma; 25 mg/quarter per milking) for 3 d. After
5-HT infusion, animals were monitored for an addi-
tional 7 d.
Measures of Potential Systemic Effects
The following measurements were obtained twice
daily (0500 and 1700 h) on each cow: RR (counted by
visual observation), EVHL (measured by a close cham-
ber evapometer; Delfin Technologies, Kuopio, Finland),
LU and RU surface temperatures (using an infrared
thermister, Raytek, Santa Cruz, CA), and RT (YSI in-
struments, Yellow Springs, OH). Blood samples were
obtained daily via the coccygeal vein, and plasma was
harvested by centrifugation (3,000 × g) for 20 min at
4°C. Concentration of plasma NEFA and glucose were
measured in all samples (NEFA interassay CV = 7.98%,
NEFA intraassay CV = 8.30%; glucose interassay CV =
6.74%, intraassay CV = 6.58%; Wako Chemicals, USA,
Richmond, VA).
Statistical Analysis
Cell Culture Experiment. A one-way ANOVA was
conducted on quantitative real-time reverse-transcrip-
tion-PCR data using gene expression relative to the
negative control (lactogenic media, without PRL) in a
respective sample, with the PROC MIXED procedure
of SAS (SAS, 9.1, 2001; SAS Institute, Cary, NC).
Graphical representation of data is represented by ex-
pression of treatments relative to the negative control
(2−∆∆CT). The∆∆CT was calculated as∆CT of a respec-
tive treatment minus ∆CT of the negative control.
Animal Experiment. Two linear mixed models with
repeated measures over twice daily milking time were
used in the study. One model was used for intramam-
mary infusion where milk and composition responses
were measured on each udder within the animal.
Yijk =  + τi + γk + (τγ)ik + BXij + bij + εijk,
where Yijk is the response for the ith udder in jth cow
at kth milking time adjusted for BXij, the baseline re-
sponse just before infusion for the ith udder in the jth
cow (B is the regression coefficient). The fixed effects
are , the mean response; τi, the effect of the ith udder
treatment; γk, the effect of the kth milking time; (τγ)ik,
the interaction effect of the ith udder treatment and
the kth milking time. The random effect bij is the be-
tween-cow error associated with treatment given udder
i for cow j, whereas εijk is the within-subjects error
associated with ith udder treatment given to the jth cow
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on the kth day. The bij are independently, identically
distributed with a mean of 0 and a variance σ2b. They
are independent of εijk, which are assumed to be multi-
variate normal with mean zero and covariance matrix
R, where R is a block diagonal matrix, with one block,
Σ, for each udder by cow within treatment.
The other model was for responses measured on the
whole cow such as glucose, NEFA, LU, RU, SR, RT,
and RR.
Yijk =  + τi + γk(τi) + bij + εijk,
where Yijk is the response for the ith treatment period
in jth cow at kth day,  is the mean response, τi is the
effect of the ith treatment period, γk(τi) is the effect of
the kth day nested in ith treatment period. The random
effect of the jth cow in ith period is bij, whereas εijk is
the period for the jth cow at the kth day. The bij are
independently, identically distributed with a mean of
0 and a variance σ2b. They are independent of εijk, which
are assumed to be multivariate normal with mean zero
and covariance matrix R, where R is a block diagonal
matrix, with one block, Σ, for each cow within treat-
ment period.
RESULTS
Cell Culture Experiment
The cell culture model used was a lactogenic rather
than a galactopoietic model because there is presently
no in vitro model of galactopoiesis. In this model, a
serum-free growth medium supplemented with IGF-I
and EGF was used to promote proliferation of BMEC
for 8 d, before the induction of differentiation. Bovine
MEC embedded in collagen gels differentiate in re-
sponse to a lactogenic complex consisting of IGF-I, PRL,
and HC, as well as releasing the gel from culture plate
well (Steining, 2005; Steining et al., 2008). Lactogenic
treatment induces dramatic morphological and ultra-
structural differentiation representative of aBMECun-
dergoing stage I lactogenesis (Steining, 2005; Steining
et al., 2008). Prolactin upregulated expression of the
TPH-1 gene regardless of treatment (P < 0.004, Figure
1), whereas PCPA, particularly in the absence of PRL,
downregulated its expression (P < 0.0001, Figure 1). In
5-HT treated cultures with PRL, TPH-1 expression was
upregulated (P < 0.05) relative to the negative control
or 5-HTwithout PRL. Thus, PRL appears to upregulate
expression of TPH-1 in BMEC and blocking TPH-1 en-
zyme activity, or the 5-HT receptor(s) was associated
with downregulation of the TPH-1 gene.
The effects of 5-HT, the nonselective 5-HT receptor
antagonist (METH), and an inhibitor of TPH-1 activity
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Figure 1. Effects of serotonergic agents with and without prolactin (PRL) on tryptophan hydroxylase 1 (TPH-1) mRNA expression. Graph
represents relative TPH-1 mRNA expression of treatments to control (CTRL) without PRL (negative control). Relative expression was
calculated using 2−∆∆Ct method (Livak and Schmittgen, 2001). Statistical analysis was conducted on relative expression. Serotonin (5-HT)
with PRL increased (P < 0.001) TPH-1 expression relative to all treatments except the control with PRL.
(PCPA) on milk protein gene expression were all tested
using IGF-1 and hydrocortisone in the culture media
with andwithout the presence of PRL.Exogenous 5-HT,
with and without PRL, downregulated α-lactalbumin
mRNA expression relative to the control with PRL and
PCPA with PRL (P < 0.05; Figure 2). The negative ef-
fects of 5-HT on α-lactalbumin mRNA expression were
Figure 2. Effects of serotonergic agents with and without prolactin (PRL) on α-lactalbumin mRNA expression. Graph represents relative
α-lactalbumin mRNA expression of treatments to control (CTRL) without PRL (negative control). Relative expression was calculated using
2−∆∆Ct method (Livak and Schmittgen, 2001). Statistical analysis was conducted on relative expression values. Serotonin (5-HT) with
and without PRL decreased (P < 0.001) α-lactalbumin mRNA expression compared with CTRL with and without PRL. Addition of p-
chlorophenyalanine (PCPA), a TPH-1 inhibitor, with PRL increased α-lactalbumin gene expression relative to all treatments (P < 0.01).
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rescued by the presence of METH with and without
PRL, and upregulated by the presence of PCPA with
PRL (P < 0.01; Figure 2). Additionally, β-casein mRNA
expression was downregulated by exogenous 5-HT and
exhibited expression levels similar to the control with-
out PRL (Figure 3). Downregulation of TPH-1 activity
with PCPA, in combination with PRL, upregulated β-
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Figure 3. Effects of serotonergic agents with and without prolactin (PRL) on β-casein mRNA expression. Graph represents relative β-
casein mRNA expression of treatments to control (CTRL) without PRL (negative control). Relative expression was calculated using 2−∆∆Ct
method (Livak and Schmittgen, 2001). Statistical analysis was conducted on relative gene expression values. The bovine mammary epithelial
cells cultured with serotonin (5-HT; 4.2 g/mL), with and without PRL (100 ng/mL), decreased β-casein mRNA expression (P < 0.001).
Addition of p-chlorophenyalanine (PCPA; 3.98 g/mL; a TPH-1 inhibitor), with PRL, caused an increase in β-casein mRNA expression
relative to all treatments, except the CTRL with PRL. Addition of methysergide (METH, 9.4 g/mL) increased β-casein gene expression
relative to 5-HT treatments (P < 0.05).
casein mRNA expression relative to all treatments (P
< 0.001; Figure 3).
Milk Yield and Composition
TheMY responses from the in vivo study are shown in
Figures 4 and 5 and Table 3.Whole udderMY increased
(10.9%; P < 0.01; Figures 4 and 5) during METH infu-
sion, and both udder halves responded similarly (P >
0.05; Table 3). Milk yield from both udder halves de-
creased 11.1% during 5-HT infusion (P < 0.05), and both
udder halves responded similarly (P < 0.05; Table 3).
These data indicate that the half-udder designwas com-
promised by crossover or systemic effects of the com-
pounds tested. Milk production did not differ between
treated and control halves throughout the study (P >
0.05).
Although there were no treatment effects on milk
lactose percentage during METH infusion (P > 0.05;
Table 4), there was a period × treatment interaction (P
< 0.05; Table 4) as it decreased (3.2%) during theMETH
infusion relative to the preinfusion period. Compared
with controls, infusing 5-HT tended to decrease milk
lactose content 5.3% compared with SAL infusion (P =
0.06; Table 5).
Milk protein percentage was decreased (2.0%; P <
0.01; Table 4) during METH and SAL infusion com-
pared with postinfusion levels. Serotonin and SAL infu-
sion increasedmilk protein content 7.3% comparedwith
the postinfusion period. Infusing METH, 5-HT or SAL
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did not alter milk fat percentage (P > 0.05; Tables 4 and
5). The changes inmilk compositionwere detectable but
quite small. However, large changes in component yield
occurred because of the shift in milk volume. For in-
stance, milk lactose yield declined 28% from pre- to
post-5-HT infusion, whereasmilk protein yield declined
20% during the same period.
Systemic Effects
Serotonin and SAL infusion increased EVHL during
the infusion period by 33% compared with the postinfu-
sion period (P < 0.0001; Table 6), tended to increase
EVHL by 16.7% compared with the preinfusion period
(P = 0.06; Table 6), and EVHL was 21.6% higher pre-
5-HT infusion comparedwith post-5-HT infusion period
(P < 0.01; Table 6). Infusing 5-HT reduced EVHL com-
pared with post-METH infusion (P < 0.01; Table 6);
additionally, EVHL was 28.8% higher during METH
infusion compared with post-5-HT infusion period (P <
0.0001; Table 6). Serotonin infusion increased EVHL
compared with post-METH infusion by 19.1% (P < 0.01;
Table 6).
Infusing 5-HT and SAL tended to increase LU tem-
perature by 1.2% compared with post-5-HT infusion
period (P = 0.07; Table 6). Left udder temperature was
1.6% higher post-METH infusion compared with post-
5-HT infusion period (P < 0.01; Table 6), andLU temper-
ature was 1.8% higher prior to METH infusion com-
pared with post-5-HT infusion (P < 0.01; Table 6). Infus-
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Figure 4. Average whole udder daily milk yield for whole udders of cows treated utilizing a half-udder model, with methysergide (METH)
or saline (SAL) infusion on d 8, 9, and 10 and treated with serotonin (5-HT) or SAL on d 18, 19, and 20. Graph represents average daily
whole-udder MY throughout the entire experiment.
ing METH tended increase RU temperature by 1.4%
compared with 5-HT infusion period (P = 0.07; Table
6). Right udder temperature was 2.4% higher before
METH compared with the post-5-HT infusion period (P
< 0.0001; Table 6). Serotonin infusion resulted in 1.4%
decrease in RU temperature compared with post-
METH infusion period (P = 0.01; Table 6). Serotonin
infusion resulted in a 3.0% decrease in rectal tempera-
ture compared with pre-5-HT infusion period and 4.1%
compared with post-5-HT infusion period (P = 0.01;
Table 6). No effects of 5-HT or METH infusion were
Table 3. Average half-udder milk yields during the 6 milkings pre-, during, and post-serotonin (5-HT),
methysergide (METH), and saline (CTL) infusions1
Treatment CTL (SEM) TRT (SEM) Mean2 (SEM)
Pre-METH 5.92 (0.81) 4.92 (0.69) 5.34a (0.64)
METH 5.93 (0.81) 5.17 (0.69) 5.48a (0.58)
Post-METH 6.01 (0.81) 4.89 (0.69) 5.30ab (0.48)
Pre-5-HT 4.32 (0.69) 5.29 (0.81) 4.76ab (0.64)
5-HT 3.50 (0.69) 4.23 (0.81) 4.23ab (0.58)
Post-5-HT 3.69 (0.69) 4.38 (0.81) 4.04b (0.48)
a,bValues with different superscripts differ, P < 0.05.
1Average of 6 milkings for each udder half during each period. Udder halves did not differ between
treatments.
2Mean milk yield for all udder halves during the respective period (kg/d).
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evident for NEFA or glucose concentration or RR (P >
0.05; Tables 6 and 7).
DISCUSSION
Serotonin’s role has not previously been evaluated in
BMEC. There have been reports demonstrating that 5-
HT affects teat smooth muscle motility in the bovine
(Vandeputte-Van Messon et al., 1985) and mammary
vasculature contractility in the sow (Busk et al., 1999).
We have demonstrated that TPH-1 (the rate limiting
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Figure5.Averagemilk yield (MY) forwhole udder for eachmilking
during methysergide (METH) and saline (SAL) infusion (d 8, 9, and
10; 2 milkings per day) and during serotonin (5-HT) and SAL infusion
(d 18, 19, and 20; 2 milkings per day). Graph represents average
daily MY within the 2 treatment periods (METH or 5-HT infusion
periods). Milk yield increased over time in both udder halves during
the METH and SAL infusion period (P < 0.001). Milk yield decreased
over time in both udder halves during 5-HT and SAL infusion period
(P < 0.01).
enzyme for 5-HT synthesis) is expressed in BMEC and
is upregulated by PRL (Figure 1; P < 0.001) and was
decreased by PCPA, which blocks TPH-1 action, rela-
tive to the control with PRL (Figure 1; P < 0.0001).
Furthermore, adding 5-HT to cultures containing lacto-
genic medium reduced mRNA expression of α-lactalbu-
min and β-casein (Figures 2 and 3). Downregulation of
milk protein mRNA expression by 5-HT suggest that
5-HT serves as a negative regulator of lactation. Addi-
tionally, rescue or enhancement of milk protein gene
expression by inhibiting 5-HT synthesis or downregula-
tion of 5-HT receptor(s) further supports this hypothe-
sis. Similar results were observed in primary mouse
mammary epithelial cells (Matsuda et al., 2004). As
stated earlier, in this study as well as Matsuda et al.
(2004) and Stull et al. (2007), the in vitro models are
Table 4. Effects of intramammary infusions of methysergide (METH) on half-udder milk composition in
Holstein cows1
Pre-METH METH Post-METH P-value2
Variable CTL TRT CTL TRT CTL TRT SEM Period Udder Interaction
Fat, % 3.4 3.4 3.2 3.3 3.1 3.2 0.11 0.19 0.62 0.88
Lactose, % 4.6 4.7 4.5 4.5 4.5 4.6 0.07 0.01 0.67 0.04
Protein, % 3.4 3.3 3.3 3.3 3.4 3.4 0.03 <0.001 0.78 0.64
SCC 239.1 195.4 335.0 809.0 256.6 280.1 172.4 0.003 0.53 0.03
1Data represent average concentrations of milk components during pre-METH infusion, METH intramam-
mary infusion, and post-METH infusion. METH infusion of 20 mg/quarter per d in a half-udder design
using contralateral quarters, with the control half being infused with SAL. CTL = saline-infused udder half,
TRT = METH-infused udder half.
2Significance of effects of the interaction between period and udder, period, and udder.
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all lactogenic as opposed to galactopoietic. In the case
ofα-lactalbumin, a protein necessary for lactose synthe-
sis, PCPA with PRL resulted in the highest level of
mRNA expression. Inhibiting 5-HT receptor(s) with
METH, with and without PRL, rescued α-lactalbumin
gene expression relative to 5-HT treated cells with and
without PRL. The β-casein mRNA expression was also
increased by PCPA with and without PRL and METH
with and without PRL compared with 5-HT with and
without PRL. The largest increase in both α-lactalbu-
min and β-casein mRNA expression was induced by
the TPH-1 action inhibitor, PCPA in combination with
PRL, indicating that both inhibition of 5-HT synthesis
and stimulation by PRL is important in upregulating
milk protein gene expression. Further increases inmilk
protein gene expression in BMEC might be possible if
the specific 5-HT receptor(s) in the mammary gland
were identified and blocked. There are numerous 5-HT
receptor subclasses that function in different manners,
such as inhibiting cAMP, stimulating cAMP, stimulat-
ing IP3 and diacylglycerol, and finally by stimulating
ion channels (Glennon et al., 1995). Recently, the 5-
HT2A receptor subtype was identified in the MCF-7 hu-
man breast cancer cell line (Sonier et al., 2006). Fur-
thermore, Stull et al. (2007) recently demonstrated that
the 5-HT7 receptor was present on the basolateral sur-
face of human andmousemammary epithelial cells and
was involved in tight junction regulation. Antagonist
and agonists for this receptor altered transepithelial
electrical resistance, suggesting that one potential feed-
back action of 5-HT involves regulation of these junc-
tions, which are critical to maintaining transepithelial
gradients. Furthermore, they suggested that the route
of 5-HT transfer from milk to the basolateral surface
of the mammary epithelial cell was paracellular. Re-
cently, we identified presence of the 5HT-1b, 2a, 2b, 4,
and 7 receptors in bovine mammary tissue (Hernandez
et al., 2008). It is possible that some or all of these
have direct or indirect effects on milk synthesis and
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Table 5. Effects of intramammary infusions of serotonin (5-HT) on half-udder milk composition in Holstein
cows1
Pre-5-HT 5-HT Post-5-HT P-value2
Variable CTL TRT CTL TRT CTL TRT SEM Period Udder Interaction
Fat, % 3.3 3.1 3.4 3.5 3.8 3.9 0.28 0.04 0.90 0.84
Lactose, % 4.6 4.3 4.6 4.3 4.6 4.4 0.09 0.80 0.07 0.72
Protein, % 3.4 3.5 3.6 3.8 3.3 3.4 0.13 0.13 0.59 0.75
SCC 197.3 248.8 504.2 548.1 326.0 309.3 93.32 0.005 0.83 0.89
1Data represent average concentrations of milk components during pre-5-HT infusion, 5-HT intramam-
mary infusion, and post-5-HT infusion. 5-HT infusion of 20 mg/quarter/d in a half-udder design using
contralateral quarters, with the control half being infused with SAL. CTL = saline infused udder half, TRT =
5-HT infused udder half.
2Significance of effects of the interaction between period and udder, period, and udder.
secretion. Thus, there are several potential sites of ac-
tion for 5-HT on milk yield. It is known that 5-HT is
a potent mammary vasoconstrictor (Vandeputte-Van
Messon et al., 1985) and affects teat smooth muscle
motility in the bovine (Vandeputte-Van Messon et al.,
1985). Therefore, determining the specific pathway in
which 5-HT exerts its inhibition is necessary to eluci-
date the mechanism of the action of 5-HT in the bovine
mammary glad.
The effects of 5-HT and METH intramammary infu-
sions on galactopoiesis have previously not been evalu-
ated in the bovine. Milk yield was altered by intramam-
mary infusions of both METH and 5-HT (Figures 4 and
5). However, data presented indicate the half-udder
model design used in this study was compromised by
crossover of the test compounds to the control udder
half. This resulted in both halves demonstrating
changes in milk yield that were consistent with the
treatments administered. During the METH infusion,
treated and nontreated udder halves demonstrated an
11% increase in yield (Figure 5). Likewise, infusing 5-
HT decreased MY (11.1%) in treated and nontreated
udder halves (Figure 5). The milk yield increase is im-
pressive when considering the fact that these animals
were more than 430 d in milk when they began the
Table 6. Effects of intramammary infusions of methysergide (METH) and serotonin (5-HT) on systemic
responses in Holstein cows1
Treatment period2 LU (°C) RU (°C) RT (°C) EVHL (g/m2 per h) RR (breath/min)
Pre 1 34.07 (0.13)a 34.02 (0.12)a 38.75 (0.19)a 50.35 (2.02)a 39.44 (0.93)a
METH 33.93 (0.19)ab 33.81 (0.19)a 38.71 (0.31)a 56.16 (3.06)a 38.50 (1.41)a
Post 1 34.00 (0.17)ab 33.82 (0.16)ab 38.52 (0.12)a 49.96 (2.69)a 39.27 (1.24)a
Pre 2 33.83 (0.20)ab 33.56 (0.19)a 38.47 (0.17)a 50.99 (3.43)a 38.67 (1.43)a
5-HT 33.89 (0.19)ab 33.35 (0.18)bc 37.31 (0.38)b 59.51 (3.02)a 39.37 (1.39)a
Post 2 33.47 (0.13)b 31.20 (0.12)c 38.85 (0.19)a 39.99 (2.02)b 38.49 (0.93)a
a–cValues within a column with different superscripts differ, P < 0.05.
1Data represent least square means of LU = left udder, RU = right udder, RT = rectal temperature, SR =
sweating rate, and RR = respiration rate. Standard errors for individual means are listed in parentheses.
2Pre 1 = pre-METH infusion period, METH = METH infusion period, Post 1 = post-METH infusion period,
Pre 2 = pre-5-HT infusion period, 5-HT = 5-HT infusion period, Post 2 = post-5-HT infusion period.
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study. Previous rodent data suggests that inhibiting
the 5-HT receptor subtypes increases mammary milk
protein gene expression, andpresumably thereforemilk
production (Matsuda et al., 2004). Increased MY in the
SAL-treated udder halves during METH infusion and
decreased MY in SAL udder halves during 5-HT treat-
ment is likely due to a systemic response (i.e., carryover)
of the infused compounds from the treated half to the
control half through the systemic circulation. Evidence
of a systemic response was indicated by marked
changes in EVHL, occurring during METH and 5-HT
infusion periods.
Although utilizing the half-udder milking model is
useful, it is possible that 5-HT and METH were used
in sufficiently high doses to reach the systemic system,
causing a crossover of treatments. Additionally, be-
cause the identity of the 5-HT receptor subtype(s) in
mammary tissue is unknown, we were unable to use
a selective/specific 5-HT receptor subtype antagonist,
which might have been effective on mammary tissue
alone.
Treatments caused small but detectable changes in
milk composition. Much greater changes were detected
in yield of milk components due to changes in milk
volume. Serotonin infusion tended to decrease milk lac-
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Table 7.Effects of intramammary infusions ofmethysergide (METH)
and serotonin (5-HT) on plasma metabolites in Holstein cows1
Treatment period2,3 NEFA, Eq/L Glucose, mg/dL
Pre 1 173.36 (24.48) 92.38 (2.47)
METH 147.11 (36.12) 92.70 (3.64)
Post 1 94.51 (30.40) 93.06 (3.13)
Pre 2 142.08 (35.10) 94.39 (3.64)
5-HT 167.29 (34.17) 91.51 (3.54)
Post 2 178.83 (24.16) 91.64 (2.41)
1Data represent least square means of NEFA and glucose concen-
trations of plasma. Standard errors for individual means are listed
in parentheses.
2Pre 1 = pre-METH infusion period, METH = METH infusion pe-
riod, Post 1 = post-METH infusion period, Pre 2 = pre-5-HT infusion
period, 5-HT = 5-HT infusion period, Post 2 = post-5-HT infusion
period.
3Values did not differ (P > 0.05).
tose percentage. Previous research indicates that 5-HT
suppresses α-lactalbumin expression in mouse and bo-
vine mammary epithelial cell culture (Matsuda et al.,
2004; Stiening, 2005). No treatment effect (vs. SAL)
on milk lactose occurred during METH infusion. Milk
lactose concentration decreased slightly during METH
infusion compared with the pre-METH infusion period.
Small increases in milk protein content were detected
during METH infusion relative to the pre- and post-5-
HT infusion periods. This is further evidence that
METH and 5-HT likely entered the systemic circula-
tion, resulting in milk protein being altered in both
udder halves (regardless of treatment) and the response
paralleled that of MY (Figure 4). In previous studies,
antagonizing the mammary epithelial cells 5-HT recep-
tors with METH has increased milk protein mRNA ex-
pression indicating that overall milk protein synthesis
should increase (Matsuda et al., 2004). Additionally,
treating mammary epithelial cells with 5-HT reduced
milk protein mRNA expression, indicating that overall
milk protein synthesis would be decreased. Although
our results are consistent with previous rodent re-
search, changes in milk composition were minor.
Milk SCC was increased during both METH and 5-
HT, regardless of treatment (vs. SAL). Intramammary
infusions can activate the mammary immune system.
This occurs due to the potential of the syringe cannula
to dilate the lumen of the streak canal, causing removal
of keratin or causing preexisting microorganisms to
move from the streak canal to the teat cistern (Akers,
2002). It is likely not due to endotoxin in the infusate
because each infusion was filtered (0.22 m) during
the infusion process. Although SCC increased above
400,000 cells/mL during infusion periods, no clinical
mastitis was detected in any of the cows as determined
by the California Mastitis Test.
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We detected reduced EVHL in cows, post-5-HT infu-
sion compared with all other periods. This may have
been associated with reduced cutaneous blood flow.
There were significant changes in LU and RU tempera-
tures and RT, further supporting the idea that both
infusions of METH and 5-HT resulted in a systemic
response. Nonthermal factors can attenuate or enhance
cold-induced vasoconstriction, heat-induced vasodila-
tion, or both, similar to thermal environmental factors
(Mekjavic and Eiken, 2006). Temperature of the RU
during 5-HT infusion was significantly lower than pre-
5-HT infusion, METH infusion period, and pre-METH
infusion. Temperature of theLUwas significantly lower
post-5-HT infusion compared with pre-METH infusion
period. Rectal temperatures of cows were decreased
during the 5-HT infusion period compared with all
other periods. Administration of 5-carboxytryptamine,
an agent that increases 5-HT levels, both systemically
and in the cerebral ventricles in guinea pigs, resulted
in a dose-dependent reduction in core body temperature
(Hagan et al., 2000). Receptors 5-HT1a/7 have been
shown to be involved in regulation of core body tempera-
ture by causing hypothermia when activated (Faure et
al., 2006). The 5-HT2a receptor has been demonstrated
to be involved in inducing hyperthermiawhen activated
(Pawlyk et al., 2006). When the 5-HT2a receptor is an-
tagonized with a systemic dose of mirtazapine, core
body temperature is decreased. Therefore, it is likely
that udder skin temperature changed due to 5-HT
reaching the systemic circulation and acting on subse-
quent receptor subtypes involved in thermoregulatory
processes.
CONCLUSIONS
These studies were designed to determine if the rate-
limiting gene for 5-HT synthesis was expressed in bo-
vinemammary tissue and upregulated by PRL. In addi-
tion we wanted to determine if 5-HT and a nonselective
antagonist of 5-HT receptors, METH, altered milk pro-
tein gene expression in BMEC and milk production in
lactating Holstein cows. Downregulation of milk pro-
tein gene expression by 5-HT in cultures of BMEC and
upregulation of these genes using inhibitors of the sero-
tonergic system support the concept that 5-HT is a feed-
back inhibitor of lactation in the bovine. The MY and
systemic response data indicate that the dose used re-
sulted in crossover of treatments compromising the
half-udder design. Milk yields did not differ between
treatment and control halves for either treatment.How-
ever, the whole udder response in MY and composition
support the concept of 5-HT as a feedback inhibitor of
lactation in the bovine. Additionally, results of this
study support the need to characterize the bovine sero-
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tonergic system (i.e., receptor subtypes and pathways
being stimulated) to fully understand howMY is locally
regulated in the mammary gland.
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